Statistical flag only — not an accusation of fraud
⚠️ This provider averages 508 services per working day — physically unusual for an individual practitioner
Based on 1.3M total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $13.9M in total Medicare payments ranks in the 99th percentile of Hematology-Oncology providers nationally.
Averaging 508 services per working day raises questions about billing patterns.
Medicare payments to this provider grew 626% from 2014 to 2023.
This provider has been statistically flagged with a risk score of 68/100. Statistical flags are not accusations of fraud.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 114% in 2019
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $47.27 | $9.90 | 4.77x | $37.37 | $474.1K | 47.9K | 33 |
| 2015 | $17.87 | $4.61 | 3.88x | $13.26 | $474.6K | 103.0K | 36 |
| 2016 | $21.23 | $5.65 | 3.76x | $15.58 | $546.4K | 96.7K | 34 |
| 2017 | $21.52 | $5.54 | 3.88x | $15.98 | $597.9K | 107.9K | 34 |
| 2018 | $26.02 | $6.27 | 4.15x | $19.75 | $605.5K | 96.6K | 35 |
| 2019 | $41.81 | $11.16 | 3.75x | $30.65 | $1.3M | 115.8K | 44 |
| 2020 | $50.35 | $13.72 | 3.67x | $36.63 | $1.9M | 138.2K | 59 |
| 2021 | $47.54 | $12.44 | 3.82x | $35.10 | $2.4M | 196.2K | 63 |
| 2022 | $50.28 | $13.42 | 3.75x | $36.86 | $2.1M | 158.3K | 57 |
| 2023 | $61.10 | $16.38 | 3.73x | $44.72 | $3.4M | 210.2K | 59 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 74.4K | $2.9M | $38.54 | 2.65x |
| J9299 | Injection, nivolumab, 1 mg | 56.9K | $1.3M | $23.14 | 2.51x |
| J2505 | Injection, pegfilgrastim, 6 mg | 378 | $1.1M | $2.8K | 4.42x |
| J0897 | Injection, denosumab, 1 mg | 51.4K | $826.5K | $16.07 | 2.79x |
| J9312 | Injection, rituximab, 10 mg | 10.0K | $705.1K | $70.20 | 2.89x |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 17.1K | $617.0K | $36.08 | 2.47x |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 65.9K | $606.1K | $9.20 | 4.97x |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | 838 | $588.2K | $701.95 | 6.07x |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 8.3K | $436.7K | $52.64 | 2.49x |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 472.5K | $397.0K | $0.84 | 3.58x |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 3.8K | $376.8K | $99.67 | 3.61x |
| J9022 | Injection, atezolizumab, 10 mg | 5.7K | $354.8K | $62.11 | 2.66x |
| J9035 | Injection, bevacizumab, 10 mg | 6.1K | $352.9K | $57.38 | 2.93x |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | 459 | $348.3K | $758.87 | 2.19x |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 2.0K | $194.6K | $97.67 | 10.94x |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 18.2K | $184.6K | $10.16 | 2.99x |
| J9173 | Injection, durvalumab, 10 mg | 2.8K | $174.4K | $62.21 | 2.33x |
| J9041 | Injection, bortezomib, 0.1 mg | 6.6K | $168.6K | $25.51 | 4.12x |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 772 | $154.6K | $200.30 | 3.59x |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | 2.6K | $144.3K | $54.63 | 2.82x |
This provider submits charges 3.81 times higher than what Medicare actually pays.
A markup ratio of 3.81x means for every $100 Medicare pays, this provider initially charges $381. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Hematology-Oncology providers in SC for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Renwick Goldberg, MD | Myrtle Beach, SC | $38.6M | ⚠️ Flagged |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data